Close

Horizon Pharma (HZNP) Tops Q4 EPS by 5c; Boosts FY15 Outlook

February 27, 2015 7:12 AM EST

Horizon Pharma (NASDAQ: HZNP) reported Q4 EPS of $0.27, $0.05 better than the analyst estimate of $0.22. Revenue for the quarter came in at $103.8 million versus the consensus estimate of $95.5 million.

2015 Guidance

The Company today announced it is raising 2015 full year guidance as follows:

                            Prior Guidance                  New Guidance
-------------------- --------------------
Net sales $425 to $450 million $450 to $475 million
Adjusted EBITDA $160 to $180 million $170 to $190 million

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Guidance

Related Entities

Earnings